ID: ALA1782170

Max Phase: Preclinical

Molecular Formula: C15H11N3O2

Molecular Weight: 265.27

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C1Cc2c([nH]c3cc[n+]([O-])cc23)-c2ccccc2N1

Standard InChI:  InChI=1S/C15H11N3O2/c19-14-7-10-11-8-18(20)6-5-13(11)17-15(10)9-3-1-2-4-12(9)16-14/h1-6,8,17H,7H2,(H,16,19)

Standard InChI Key:  QSSHEITWSXIQFH-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 265.27

Molecular Weight (Monoisotopic): 265.0851

AlogP: 1.96

#Rotatable Bonds: 0

Polar Surface Area: 71.83

Molecular Species: NEUTRAL

HBA: 2

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.12

CX Basic pKa: 1.62

CX LogP: 0.26

CX LogD: 0.26

Aromatic Rings: 3

Heavy Atoms: 20

QED Weighted: 0.48

Np Likeness Score: -0.21

References

1. Power DP, Lozach O, Meijer L, Grayson DH, Connon SJ..  (2010)  Concise synthesis and CDK/GSK inhibitory activity of the missing 9-azapaullones.,  20  (16): [PMID:20621478] [10.1016/j.bmcl.2010.06.024]

2. Akunuri R, Vadakattu M, Bujji S, Veerareddy V, Madhavi YV, Nanduri S..  (2021)  Fused-azepinones: Emerging scaffolds of medicinal importance.,  220  [PMID:33901899] [10.1016/j.ejmech.2021.113445]

Source

Source(1):

• Scientific Literature